MabVax Therapeutics Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:MabVax Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013632
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MabVax Therapeutics Inc (MabVax Therapeutics), a subsidiary of MabVax Therapeutics Holdings Inc is a biopharmaceutical company that develops and commercializes anti-cancer immunotherapies from antibody and vaccine technology. The company offers immune-oncology technology platforms such as human monoclonal antibody products and therapeutic vaccines. Its pipeline of novel human antibody-based product candidates is discovered from B cells in blood samples of patients vaccinated. MabVax also offers vaccine program for the treatment of ovarian cancer, breast cancer and neuroblastoma. The company generates pipeline of antibody based product candidates from vaccinated patients. Its human antibody technology platform surveys the protective immune response from patients to identifying the ideal monoclonal antibody candidate against a target on the surface of a cancer cell. MabVax Therapeutics is headquartered in San Diego, California, the US.

MabVax Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MabVax Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
MabVax Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
MabVax Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
MabVax Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
MabVax Therapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 9
MabVax Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
MabVax Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Mabvax Therapeutics Raises US$12 Million In Venture Financing 11
MabVax Therapeutics Raises US$5.2 Million In First Tranche Of Series B Financing 12
Partnerships 13
MabVax Therapeutics Enters into Research Agreement with Rockefeller University 13
MabVax Therapeutics Enters into Co-Development Agreement with Heidelberg Pharma 14
MabVax Therapeutics Enters into Co-development Agreement with Memorial Sloan Kettering Cancer Center 15
Equity Offering 16
MabVax Therapeutics Raises USD3 Million in Private Placement of Shares 16
MabVax Therapeutics Raises USD1.5 Million in Private Placement of Shares upon Exercise of Warrants 17
Acquisition 18
Telik Completes Acquisition of MabVax Therapeutics, Oncology Therapies Provider 18
MabVax Therapeutics Inc – Key Competitors 20
MabVax Therapeutics Inc – Key Employees 21
MabVax Therapeutics Inc – Locations And Subsidiaries 22
Head Office 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
MabVax Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
MabVax Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
MabVax Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
MabVax Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
MabVax Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
MabVax Therapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 9
MabVax Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Mabvax Therapeutics Raises US$12 Million In Venture Financing 11
MabVax Therapeutics Raises US$5.2 Million In First Tranche Of Series B Financing 12
MabVax Therapeutics Enters into Research Agreement with Rockefeller University 13
MabVax Therapeutics Enters into Co-Development Agreement with Heidelberg Pharma 14
MabVax Therapeutics Enters into Co-development Agreement with Memorial Sloan Kettering Cancer Center 15
MabVax Therapeutics Raises USD3 Million in Private Placement of Shares 16
MabVax Therapeutics Raises USD1.5 Million in Private Placement of Shares upon Exercise of Warrants 17
Telik Completes Acquisition of MabVax Therapeutics, Oncology Therapies Provider 18
MabVax Therapeutics Inc, Key Competitors 20
MabVax Therapeutics Inc, Key Employees 21

★海外企業調査レポート[MabVax Therapeutics Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Municipal Energy Agency of Nebraska:企業の発電所・SWOT分析2018
    Municipal Energy Agency of Nebraska - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Tampa Electric Co:企業の発電所・SWOT分析2018
    Tampa Electric Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Aminex PLC (AEX):石油・ガス:M&Aディール及び事業提携情報
    Summary Aminex PLC (Aminex) is an oil and gas company that explores, develops and produces oil and gas reserves in Africa. The company provides assets such as Valeni field and Viktorovka field in Moldova; West Esh el Mellaha-2 in Egypt; and Kiliwani North development, Nyuni exploration, and Ruvuma e …
  • Tokyo Broadcasting System Holdings Inc (9401):企業の財務・戦略的SWOT分析
    Tokyo Broadcasting System Holdings Inc (9401) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • MeiraGTx Holdings Plc (MGTX):製薬・医療:M&Aディール及び事業提携情報
    Summary MeiraGTx Holdings Plc (MeiraGTx) is an independent clinical-stage gene therapy company that focuses on the development of therapeutics for the treatment of eye, salivary gland and neurodegenerative diseases. The company’s pipeline of preclinical and research programs include AAV-CNGB3, for a …
  • Vericel Corp (VCEL)-製薬・医療分野:企業M&A・提携分析
    Summary Vericel Corp (Vericel) formerly Aastrom Biosciences, Inc. is a medical device company that develops patient-specific expanded cellular therapies to repair and regenerate damaged tissue for the treatment of severe, chronic ischemic cardiovascular diseases. It markets two autologous cell thera …
  • Seminole Electric Cooperative, Inc.:企業の発電所・SWOT分析2018
    Seminole Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Ascent Resources Plc (AST):石油・ガス:M&Aディール及び事業提携情報
    Summary Ascent Resources Plc. (Ascent) is an independent upstream exploration and production company. It explores for, develops and produces oil and natural gas from its project in Slovenia. It operates the Petisovci tight gas project in Slovenia. The Petisovci Tight Gas project is in proximity to t …
  • Maanshan Iron & Steel Company Limited:企業の戦略・SWOT・財務情報
    Maanshan Iron & Steel Company Limited - Strategy, SWOT and Corporate Finance Report Summary Maanshan Iron & Steel Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Qurient Co Ltd (115180)-製薬・医療分野:企業M&A・提携分析
    Summary Qurient Co Ltd (Qurient) is a biotechnology company that focuses on the development of new drugs for unmet medical needs. The company’s portfolio of pipeline products includes Q301, Q203, Q701, 5LO INH and CDK7 INH among others. The company is developing products for the treatment of atopic …
  • Teva Pharmaceutical Industries Ltd (TEVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Teva Pharmaceutical Industries Ltd (Teva) is a pharmaceutical company that carries out the research, development, manufacture and commercialization of generic and specialty medicines. It provides specialty medicines to treat disorders of the central nervous system (CNS), respiratory, cancer, …
  • Medical Depot Inc:医療機器:M&Aディール及び事業提携情報
    Summary Medical Depot Inc (Drive Medical) is a manufacturer and distributor of durable medical equipment. The company provides rollators, walkers, canes and crutches, commodes, bath safety, patient room , wheelchairs, power mobility, beds, pressure prevention, electrotherapy, lifestyle essentials, r …
  • Glowpoint, Inc. (GLOW):企業の財務・戦略的SWOT分析
    Glowpoint, Inc. (GLOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Scotiabank Private Banking:企業の戦略・SWOT・財務分析
    Scotiabank Private Banking - Strategy, SWOT and Corporate Finance Report Summary Scotiabank Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Waters Corporation:企業の戦略・SWOT・財務情報
    Waters Corporation - Strategy, SWOT and Corporate Finance Report Summary Waters Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Pivot Pharmaceuticals Inc (PVOTF):製薬・医療:M&Aディール及び事業提携情報
    Summary Pivot Pharmaceuticals Inc (Pivot Pharmaceuticals), formerly Neurokine Pharmaceuticals Inc is a biopharmaceutical company that focuses on the development and commercialization of cannabinoid based neutraceutical and pharmaceutical products. The company’s major product offerings include capsul …
  • Virginia Electric and Power Company:企業の発電所・SWOT分析2018
    Virginia Electric and Power Company - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • BPS Direct LLC:企業の戦略・SWOT・財務分析
    BPS Direct LLC - Strategy, SWOT and Corporate Finance Report Summary BPS Direct LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Transnet SOC Ltd:企業の戦略的SWOT分析
    Transnet SOC Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Earthstone Energy Inc (ESTE):企業の財務・戦略的SWOT分析
    Summary Earthstone Energy Inc (Earthstone Energy), formerly Basic Earth Science Systems Inc is an independent oil and gas company that offers acquisition, exploration, production and development of oil and gas properties. The company's activities include acquiring, drilling, developing and producing …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆